Today: 7 February 2026
Subscribe
Browse Category

NYSE:UNH News 1 February 2026 - 7 February 2026

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
·······
UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.
6 February 2026
·····
UnitedHealth stock slips in premarket after Mizuho cuts target, as Medicare Advantage pressure builds

UnitedHealth stock slips in premarket after Mizuho cuts target, as Medicare Advantage pressure builds

UnitedHealth shares fell 2.7% to $268.55 in premarket trading after Mizuho cut its price target to $350. The move follows regulatory scrutiny over Medicare Advantage payments and pharmacy benefit manager practices. Investors are watching the Feb. 25 CMS comment deadline and an April rate decision. Other managed-care stocks showed mixed premarket moves.
6 February 2026
····
UnitedHealth stock drops nearly 3% midday as Medicare Advantage rates loom — what to watch next

UnitedHealth stock drops nearly 3% midday as Medicare Advantage rates loom — what to watch next

UnitedHealth Group shares fell 2.8% to $268.23 Thursday, underperforming managed-care peers after CMS proposed a 0.09% net payment increase for Medicare Advantage in 2027 and stricter risk adjustment rules. The company expects its Medicare Advantage membership to drop by up to 1.2 million next year, according to a regulatory filing.
5 February 2026
····
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·······
UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth shares fell about 3% Wednesday, closing at $275.58, after a Cornell study linked Optum’s surgery-center acquisitions to an 11% price hike in commercial claims. Investors are watching for Medicare Advantage rate decisions in April amid ongoing regulatory scrutiny of UnitedHealth’s Optum and other managed-care firms.
4 February 2026
······
UnitedHealth stock slips after hours as Optum price-study and fresh target cuts keep UNH in focus

UnitedHealth stock slips after hours as Optum price-study and fresh target cuts keep UNH in focus

UnitedHealth shares fell 0.5% to $284.18 in after-hours trading Tuesday after JPMorgan and Truist cut price targets, citing uncertainty over Medicare Advantage rates. A new study found surgery center prices rose 11% after Optum acquisitions, increasing scrutiny of UnitedHealth’s provider deals.
4 February 2026
·······
UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom

UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom

UnitedHealth shares fell about 1.2% to $282.20 by midday Tuesday after Truist and JPMorgan cut their price targets to $370 and $389, respectively. Investors cited concerns over Medicare Advantage payment changes and rising medical costs. UnitedHealth recently projected 2026 revenue above $439 billion with adjusted earnings expected to top $17.75 per share.
3 February 2026
····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
··········
UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth Group shares fell 1.8% to $286.93 Friday as investors weighed the government’s proposed 2027 Medicare Advantage rates. The Centers for Medicare & Medicaid Services set a Feb. 25 deadline for comments and plans to announce final rates by April 6. UnitedHealth’s stock had plunged nearly 20% earlier in the week after the initial rate proposal missed analyst expectations.
1 February 2026
····
Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

The Health Care Select Sector SPDR Fund (XLV) rose 0.6% to $154.74 Friday, while the S&P 500 fell 0.43%. Healthcare and consumer staples were the only S&P sectors in positive territory as investors shifted to defensive stocks. Major managed-care shares lagged after a minimal proposed Medicare Advantage rate hike. Pfizer, Merck, and Eli Lilly report earnings next week.
1 February 2026
········
1 2 3 … 11

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop